Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial-Reference-Cited by-同舟云学术

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

Published:2009-09 Issue:14 Volume:45 Page:2496-2502
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Alkner Sara,Bendahl Pär-Ola,Fernö Mårten,Nordenskjöld Bo,Rydén Lisa

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Socialstyrelsen. Cancer incidence in Sweden 2007. In: Socialstyrelsen, editor. Swedish Cancer Registry CfE. The National Board of Health and Welfare; 2008.

2. Socialstyrelsen. Öppna jämförelser av hälso-och sjukvårdens kvalitet och effektivitet. In: Socialstyrelsen, editor. Ordförrådet AB; 2008.

3. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study;Adami;Cancer,1985

4. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy;Rutqvist;J Natl Cancer Inst,1991

5. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands;Schaapveld;Breast Cancer Res Treat,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of lag times in cancer pharmacoepidemiology: a narrative review;Annals of Epidemiology;2023-08

2. Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast Cancer;Radiology;2022-08

3. Correlates of Adjuvant Therapy Attitudes in African American Breast Cancer Patients;Journal of the National Medical Association;2020-04

4. Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors;Supportive Care in Cancer;2020-01-02

5. Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis;The Breast;2019-04